|Articles|August 1, 2009
- BioPharm International-08-01-2009
- Volume 22
- Issue 8
BioPharm International, August 2009 (PDF)
Pfizer Tackles Lean and Six Sigma
Advertisement
Articles in this issue
about 16 years ago
Use of Change-Point Analysis for Process Monitoring and Controlabout 16 years ago
Analytical Tools for Process and Product Characterizationabout 16 years ago
Laying the Foundationabout 16 years ago
Recent Patent Rulings Can Impede the Progress of Personalized Medicineabout 16 years ago
Waiting for Godot: Will Venture Funding Return?about 16 years ago
Health Reform Challenges Biotech Industryabout 16 years ago
Avoiding the Regulatory Catch 22Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
